Jennie Conroy

456 total citations
14 papers, 254 citations indexed

About

Jennie Conroy is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Computational Theory and Mathematics. According to data from OpenAlex, Jennie Conroy has authored 14 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 4 papers in Computational Theory and Mathematics. Recurrent topics in Jennie Conroy's work include Receptor Mechanisms and Signaling (12 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Neuropeptides and Animal Physiology (5 papers). Jennie Conroy is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Neuropeptides and Animal Physiology (5 papers). Jennie Conroy collaborates with scholars based in United States, Australia and Netherlands. Jennie Conroy's co-authors include David R. Sibley, R. Benjamin Free, Jack Bergman, Nancy K. Mello, Rebecca A. Roof, Cheryse A. Furman, Phil Skolnick, Julia W. Nalwalk, James G. Phillips and Trevor Doyle and has published in prestigious journals such as Brain Research, The FASEB Journal and Pain.

In The Last Decade

Jennie Conroy

12 papers receiving 254 citations

Peers

Jennie Conroy
Tanja Obradovic United States
Shaili Aggarwal United States
Sally J. McCann Australia
Bryan Roth United States
Izaak den Daas Netherlands
Tanja Obradovic United States
Jennie Conroy
Citations per year, relative to Jennie Conroy Jennie Conroy (= 1×) peers Tanja Obradovic

Countries citing papers authored by Jennie Conroy

Since Specialization
Citations

This map shows the geographic impact of Jennie Conroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennie Conroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennie Conroy more than expected).

Fields of papers citing papers by Jennie Conroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennie Conroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennie Conroy. The network helps show where Jennie Conroy may publish in the future.

Co-authorship network of co-authors of Jennie Conroy

This figure shows the co-authorship network connecting the top 25 collaborators of Jennie Conroy. A scholar is included among the top collaborators of Jennie Conroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennie Conroy. Jennie Conroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Jain, Prashi, R. Benjamin Free, Jennie Conroy, et al.. (2020). Development of pyrimidone D1 dopamine receptor positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 31. 127696–127696. 6 indexed citations
2.
Conroy, Jennie, R. Benjamin Free, Noel Southall, et al.. (2018). Identification of Positive Allosteric Modulators of the D1 Dopamine Receptor That Act at Diverse Binding Sites. Molecular Pharmacology. 94(4). 1197–1209. 29 indexed citations
3.
Conroy, Jennie, R. Benjamin Free, Noel Southall, et al.. (2018). Positive Allosteric Modulators of the D 1 Dopamine Receptor Act at Diverse Binding Sites. The FASEB Journal. 32(S1). 1 indexed citations
4.
Conroy, Jennie, R. Benjamin Free, Noel Southall, et al.. (2016). Structurally Diverse Positive Allosteric Modulators of the D 1 Dopamine Receptor Potentiate G‐Protein and β‐Arrestin‐Mediated Signaling. The FASEB Journal. 30(S1). 1 indexed citations
5.
Conroy, Jennie, et al.. (2015). PNA-Based Multivalent Scaffolds Activate the Dopamine D2 Receptor. ACS Medicinal Chemistry Letters. 6(4). 425–429. 9 indexed citations
6.
Conroy, Jennie, R. Benjamin Free, & David R. Sibley. (2015). Identification of G Protein-Biased Agonists That Fail To Recruit β-Arrestin or Promote Internalization of the D1 Dopamine Receptor. ACS Chemical Neuroscience. 6(4). 681–692. 56 indexed citations
7.
Xiao, Jingbo, R. Benjamin Free, Elena Barnaeva, et al.. (2014). Discovery, Optimization, and Characterization of Novel D2 Dopamine Receptor Selective Antagonists. Journal of Medicinal Chemistry. 57(8). 3450–3463. 21 indexed citations
8.
Free, R. Benjamin, Nicole Miller, Trevor Doyle, et al.. (2014). (-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signaling. Psychopharmacology. 232(5). 917–930. 23 indexed citations
9.
Conroy, Jennie, Julia W. Nalwalk, James G. Phillips, & Lindsay B. Hough. (2013). CC12, a P450/epoxygenase inhibitor, acts in the rat rostral, ventromedial medulla to attenuate morphine antinociception. Brain Research. 1499. 1–11. 11 indexed citations
10.
Moritz, Amy E., R. Benjamin Free, Jennie Conroy, et al.. (2013). Identification of a novel dopaminergic agonist that selectively activates the D3 dopamine receptor. The FASEB Journal. 27(S1).
11.
Xiao, Jingbo, R. Benjamin Free, Elena Barnaeva, et al.. (2013). Discovery, optimization, and characterization of a novel series of dopamine D2 versus D3 receptor selective antagonists.
12.
Roof, Rebecca A., Jack Bergman, Jennie Conroy, et al.. (2012). Buspirone is a potent antagonist at D 3 and D 4 Dopamine Receptors and attenuates the reinforcing effects of cocaine in a primate model. The FASEB Journal. 26(S1). 1 indexed citations
13.
Bergman, Jack, Rebecca A. Roof, Cheryse A. Furman, et al.. (2012). Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors. The International Journal of Neuropsychopharmacology. 16(2). 445–458. 84 indexed citations
14.
Hough, Lindsay B., Julia W. Nalwalk, Jun Yang, et al.. (2011). Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic. Pain. 152(4). 878–887. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026